Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Crit Rev Immunol ; 40(6): 537-542, 2020.
Article in English | MEDLINE | ID: mdl-33900697

ABSTRACT

The pandemic caused by the SARS-CoV-2 has made new treatments a goal for the scientific community. One of these treatments is Ivermectin. Here we discuss the hypothesis of dysbiosis caused by the use of Ivermectin and the possible impacts on neuroinflammatory diseases after the end of the pandemic.


Subject(s)
COVID-19/epidemiology , COVID-19/virology , Dysbiosis/epidemiology , SARS-CoV-2 , Autoimmune Diseases of the Nervous System/epidemiology , Autoimmune Diseases of the Nervous System/etiology , COVID-19/complications , Disease Susceptibility , Dysbiosis/etiology , Humans , Ivermectin/adverse effects , Ivermectin/therapeutic use , SARS-CoV-2/drug effects , SARS-CoV-2/immunology , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL
...